Ceylon Hospitals Plc

CHL.N0000Moderately undervalued

Healthcare · Hospital/Nursing Management

Ceylon Hospitals PLC (Durdans) is a Sri Lanka-based private healthcare group that provides hospital-based care and an expanding network of diagnostic and laboratory services.

CHL shares are up 34.4% over the past year and last closed at Rs 61.00 on Sep 30, 2026.

Voting
Rs 61.00
+0.00%
Price history
+34.44%

Monthly seasonality

Monthly total returns by year and calendar month
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026+30.1-3.2-29.4+9.3-5.5+3.7-3.6+1.1-2.7+0.0+0.0+0.0
2025+8.8+0.0+3.0-2.2+12.0+2.1+18.9+8.8+2.2+50.7-6.6+1.5
2024+5.4-9.1+4.1+4.2-3.0-1.2+1.3-4.0+0.7+0.0-1.7+0.0
2023-2.8+0.8+0.9-9.8-3.9-1.8+8.8-4.0+0.8+3.2+0.0-7.7
2022+8.6-9.1-32.3+13.3+10.0-9.1+19.1-1.5+0.0+3.3-1.8+5.1
2021+1.0+0.0-2.9+2.0+1.2+0.5+1.9-0.2+14.3+4.9+5.5+12.6
2020+5.1+5.9+0.0+0.0+0.0-10.9+12.4-3.2+10.2+3.0+6.1-1.6
2019+5.5+0.1-2.7+2.5+8.0+0.4-5.2+5.1-9.8+6.6+0.3+0.0
2018-2.4+1.9-3.0+6.3-0.8-9.8+2.2+4.2-6.2-2.8+6.8-9.9
2017+3.0-2.2+7.8-5.2+5.6+5.3-12.5-1.0-1.8+5.9+0.0+0.0
2016-9.8+0.0+0.0+0.0+10.5+2.4-7.0-3.4+3.5+9.3+0.0+0.0
2015-5.5-0.9+4.5+0.0+0.0+4.4-0.4+0.6+4.4-12.2+0.0+0.0
2014-2.7+7.9-0.4-2.6-1.8-4.5+7.6-6.9-0.9+6.7-5.6+11.7
2013+5.4+7.2-3.8+1.9+4.0-0.9+0.1+1.8+2.8+0.0+0.0+0.0
2012+0.0+0.0+0.0+3.6-6.8+15.0-5.6+5.3+12.5+0.2+6.4-4.2
Average+3.6-0.1-4.5+1.9+2.3-0.3+2.5+0.2+2.0+5.6+0.8+0.7
ASPI average+3.1-2.7-4.7+2.0+0.2+0.8+3.1+2.2+3.2-0.1+1.0+3.0
Median+4.1+0.0-1.5+2.2+1.2+0.4+1.3-0.2+0.8+3.3+0.0+0.0
% up64%46%42%67%54%53%60%47%60%71%45%36%
P/E
10.7
P/B
0.85
EPS
Rs 5.68
Div Yield
1.80%
Market Cap
Rs 9.7B
Beta
1.03
ROE
8.1%
Op Margin
14.3% (-2.3pp)

Fundamentals

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue
Rs 11.0B
+12.6%
Rs 9.8B
+6.5%
Rs 9.2B
+15.8%
Rs 7.9B
+0.8%
Rs 7.8B
+41.4%
Rs 5.5B
-7.2%
Rs 6.0B
+2.9%
Rs 5.8B
+1.3%
Operating profit
Rs 1.6B
+34.5%
Rs 1.2B
+64.6%
Rs 703.9M
-25.2%
Rs 941.0M
-30.9%
Rs 1.4B
+112.8%
Rs 639.8M
-0.7%
Rs 644.6M
+3.5%
Rs 622.9M
-5.5%
Net profit
Rs 1.1B
+44.9%
Rs 726.0M
+60.0%
Rs 453.8M
-30.4%
Rs 651.7M
-41.3%
Rs 1.1B
+84.8%
Rs 600.3M
+28.5%
Rs 467.1M
+24.1%
Rs 376.3M
-22.9%
EPS
5.68
-65.3%
16.38
+41.3%
11.59
-31.3%
16.88
-41.8%
29.00
+75.3%
16.54
+38.9%
11.91
+25.4%
9.50
-20.0%

Compared with the same period a year earlier.

Per-share figures are as reported, not adjusted for splits.

Recent dividends

  • 2026 · first interimRs 1.10
  • 2025 · first interimRs 4.00
  • 2024 · first interimRs 2.00
  • 2023 · first interimRs 2.30
  • 2022 · first interimRs 5.00
  • 2021 · first interimRs 3.20
  • 2020 · first and finalRs 2.20
  • 2019 · second interimRs 3.60
Peer comparison5 peers in Healthcare
Rs 28.10
P/E
6.4
P/B
1.25
ROE
11.69%
Yield
0.00%
Rs 114.75
P/E
10.8
P/B
1.57
ROE
14.56%
Yield
2.61%
Rs 11.50
P/E
15.3
P/B
2.67
ROE
16.28%
Yield
0.00%
CHL.N0000 · this company
Rs 61.00
P/E
10.7
P/B
0.85
ROE
8.07%
Yield
1.80%
Rs 22.10
P/E
43.9
P/B
7.92
ROE
4.65%
Yield
0.00%
Rs 12.80
P/E
8.0
P/B
0.92
ROE
11.46%
Yield
0.00%
Peer median · 5 companies
P/E 10.8P/B 1.57Yield 0.00%

About Ceylon Hospitals Plc

Ceylon Hospitals PLC (Durdans) is a Sri Lanka-based private healthcare group that provides hospital-based care and an expanding network of diagnostic and laboratory services. The Group's narrative focuses on delivering inpatient, outpatient and day-case care alongside specialised clinical services supported by surgical and diagnostic capabilities. Operations include the main Durdans hospital and an islandwide laboratory and diagnostics network, complemented by education and workforce development through the Amrak Institute of Medical Sciences and related subsidiaries. Named subsidiaries in the Group scope include Durdans Medical & Surgical Hospital (Pvt) Ltd, Amrak Institute of Medical Sciences (Pvt) Ltd and Ceygen Biotech (Pvt) Ltd. The Group operates across Sri Lanka with its head office in Colombo and has expanded services into regions including Galle and Kurunegala, maintaining standards aligned with international accreditation and pursuing digital and service expansion initiatives.

AI analysis

neutral

Ceylon Hospitals delivered 44.9% annual net-profit growth, but the latest quarter showed weaker operating profit. The key tension is improving earnings against softer operating momentum.

Read the full report (Aug 14, 2026) →

News sentiment

Describes news flow, not a forecast
Last 30 days
Not enough news to read

No scored news in the last 30 days.

24 months positive negative 3-month net
Jan 25: 4 articles, net +0.25Jun 25: 1 articles, net +1.00May 26: 1 articles, net +1.00Jun 24Oct 24Feb 25Jun 25Oct 25Feb 26
Recent news
View all news →
Daily FT·Jan 10, 2026·Market commentary
CSE ends week with ASPI 3.4% on the up and Rs. 265 b value

Colombo bourse closed the week up 3.45% as the ASPI rose 0.54% yesterday to 23,654.30, with the market gaining about Rs. 264.8 billion in value for the week and daily turnover over Rs. 8.5 billion; top contributors included JKH, COMB, VONE, CARS and NTB.

Consumer Staples (FMCG)
EconomyNext·Jan 7, 2026·Share split / sub-division
Sri Lanka’s Durdans announces share sub division

Ceylon Hospitals (Durdans) will seek shareholder approval to subdivide voting shares from 31,762,723 to 127,050,892 and non-voting shares from 10,133,765 to 40,535,060 (1-for-4); stated capital will remain at 1,778,802,331.50 rupees and the plan is pending regulatory approval.

Healthcare & Pharma
Daily FT·Jan 7, 2026·Share split / sub-division
Durdens Hospital proposes four-for-one share split

Ceylon Hospitals (Durdens) will propose a 4-for-1 subdivision of both ordinary voting and non-voting shares, subject to regulatory and shareholder approvals. Voting shares would rise to 127,050,892 and non-voting to 40,535,060, with stated capital unchanged at Rs. 1,778,802,331.50.

Healthcare & Pharma
CSE filing·Jan 6, 2026
Subdivision of shares

Share split · 1:4 · XD Mar 5, 2026

Split issue

Healthcare & Pharma
Ada Derana·Dec 22, 2025·Management or board change
New leadership takes office at the Association of Private Hospitals and Nursing Homes

The Association of Private Hospitals and Nursing Homes appointed a new Governing Council for 2025–2027, naming Raveen Wickramasinghe as President. The council includes representatives from Asiri, Nawaloka, Lanka, Ceylon and Singhe hospitals and will focus on policy advocacy, quality and capacity building.

Healthcare & Pharma
Daily FT·Oct 28, 2025·Market commentaryPositive
CSE opens week in red

Colombo market opened lower as the ASPI fell 0.10% to 22,788.79; major movers included Colombo Dockyard (DOCK +24.20%) and Ceylon Hospitals (CHL +25.64%), while C T Holdings, Central Finance and Richard Pieris were among the session's laggards.

EconomyNext·Aug 4, 2025·Award or certificationPositive
Sri Lanka’s Top 100 Most Valuable Brands by BrandFinance

Brand Finance published Sri Lanka's 100 Most Valuable Brands for 2025, ranking Bank of Ceylon top with a brand value of Rs.57,411m; Commercial Bank, Dialog and People’s Bank follow the top positions. The list covers firms across banking, telecoms, FMCG, healthcare, hospitality and other sectors.

Consumer Staples (FMCG)Healthcare & PharmaTourismIT & Digital

Healthcare sector: what is happening

Last 14 days to Sep 30, 2026

Healthcare news centred on public-sector capacity and control. The Government will take full ownership of Neville Fernando Hospital, with the Sri Lanka Air Force managing daily operations and Treasury funding salaries and operations. Cabinet approved 39 hospital infrastructure projects for the public investment programme, alongside NIC-linked e-health records, while four hospital construction projects were launched, including cardiology and emergency facilities.

Auto-generated from 4 sector news articles over 14 days. Not investment advice.